Loading market dashboard
Xilio Therapeutics, Inc.
XLOHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Xilio Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $2.34M | $2.34M - $2.34M | $503.6K | -$2.85 | 1 |
| Dec 2029 | $4.15M | $4.15M - $4.15M | $893.1K | -$2.90 | 1 |
| Dec 2028 | $7.43M | $7.43M - $7.43M | $1.60M | -$3.64 | 1 |
| Dec 2027 | $28.55M | $28.55M - $28.55M | $6.14M | -$2.59 | 1 |
| Dec 2026 | $36.01M | $36.01M - $36.01M | $7.75M | -$3.02 | 1 |
| Dec 2025 | $41.00M | $41.00M - $41.00M | $8.82M | -$6.86 | 1 |
| Dec 2024 | $7.70M | $6.19M - $9.21M | $1.66M | -$15.943 | 2 |
| Dec 2023 | $2.36M | $2.36M - $2.36M | $507.2K | -$1.491 | 1 |